CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 305B2 Other 305B2
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Grant or award Director acquired 6,333 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- S-3ASR Offering Registration Statement
- 4 Open-market sale President & CEO sold 148,517 shares at $33.32 ($4,947,888)
- 4 Open-market sale Chief Financial Officer sold 21,217 shares at $33.47 ($710,141)
- 4 Open-market sale Chief Operating Officer sold 18,217 shares at $33.47 ($609,636)
- 10-Q Report Quarterly Report
- 144 Insider Sale of Securities
- 8-K Event Results of operations
Page 1 of 33 · 652 filings